Celltrion presents Zymfentra clinical data at gastroenterology meeting
Biopharmaceutical firm Celltrion USA scheduled two oral presentations evaluating Zymfentra in Crohn s disease and ulcerative colitis at the American College of Gastroenterology conference
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.